Lymphocyte subgroups in children with CCHF: A marker for prognosis

Journal of Infection

Volumn 59, Issue 4, 2009, Pages 291-293

  Tezer, Hasan ^a   Sayli, Tülin Revide ^a   Metin, Ayşe ^a   Köker, Yavuz ^a   Devrim, Ilker ^a   Ergönül, Önder ^b  

^a MINISTRY OF HEALTH   (Turkey)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN;

ADOLESCENT; BLOOD CLOTTING DISORDER; CD3+ T LYMPHOCYTE; CD4 LYMPHOCYTE PERCENTAGE; CD8+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DISEASE SEVERITY; HELPER CELL; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; LABORATORY TEST; LETTER; LEUKOPENIA; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; PRESCHOOL CHILD; PROGNOSIS; SCHOOL CHILD; TURKEY (REPUBLIC); VIRUS HEMORRHAGIC FEVER; VIRUS STRAIN; VIRUS VIRULENCE;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTES;

EID: 72049123753     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.07.011     Document Type: Letter

References (10)

1. Ergönül O., Celikbaş A., Dokuzoguz B., Eren S., Baykam N., and Esener H. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis 39 (2004) 284-287
2. Centers for Disease Control and Prevention. Viral hemorrhagic fever: initial management of suspected and confirmed cases. MMWR Morb Mortal Wkly Rep 32 Suppl. 2 (1983) 27S-38S
3. Whitehouse C.A. Crimean-Congo hemorrhagic fever. Antiviral Res 64 (2004) 145-160
4. Ikincioǧullari A., Kendirli T., Doǧu F., Eǧin Y., Reisli I., Cin S., et al. Peripheral blood lymphocyte subsets in healthy Turkish children. Turk J Pediatr 46 (2004) 125-130
5. Villinger F., Rollin P.E., Brar S.S., Chikkala N.F., Winter J., Sundstrom J.B., et al. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis 179 Suppl. 1 (1999) S188-S191
6. Schnittler H.J., and Feldmann H. Viral hemorrhagic fever - a vascular disease?. Thromb Haemost 89 (2003) 967-972
7. Bray M., and Geisbert T.W. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 37 (2005) 1560-1566
8. Aki{dotless}nci{dotless} E., Yi{dotless}lmaz M., Bodur H., Ongürü P., Bayazi{dotless}t F.N., Erbay A., et al. Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever. Int J Infect Dis (2008 Dec 26) [Epub ahead of print]
9. Yilmaz M., Aydin K., Akdogan E., Sucu N., Sonmez M., Omay S.B., et al. Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever. J Clin Virol 42 (2008) 415-417
10. Sharifi-Mood B., Mardani M., Keshtkar-Jahromi M., Rahnavardi M., Hatami H., and Metanat M. Clinical and epidemiologic features of Crimean-Congo hemorrhagic fever among children and adolescents from southeastern Iran. Pediatr Infect Dis J 27 (2008) 561-563